These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24394906)

  • 1. BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Mak M; Deptuła-Jarosz M; Gołąb-Janowska M; Droździk M; Sławek J
    Neurosci Lett; 2014 Feb; 561():86-90. PubMed ID: 24394906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease.
    Guerini FR; Beghi E; Riboldazzi G; Zangaglia R; Pianezzola C; Bono G; Casali C; Di Lorenzo C; Agliardi C; Nappi G; Clerici M; Martignoni E
    Eur J Neurol; 2009 Nov; 16(11):1240-5. PubMed ID: 19538209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson's disease.
    Gao L; Díaz-Corrales FJ; Carrillo F; Díaz-Martín J; Caceres-Redondo MT; Carballo M; Palomino A; López-Barneo J; Mir P
    Acta Neurol Scand; 2010 Jul; 122(1):41-5. PubMed ID: 20085561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease.
    Svetel M; Pekmezovic T; Markovic V; Novaković I; Dobričić V; Djuric G; Stefanova E; Kostić V
    Eur Neurol; 2013; 70(5-6):257-62. PubMed ID: 24051673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF polymorphism associates with decline in set shifting in Parkinson's disease.
    van der Kolk NM; Speelman AD; van Nimwegen M; Kessels RP; IntHout J; Hakobjan M; Munneke M; Bloem BR; van de Warrenburg BP
    Neurobiol Aging; 2015 Mar; 36(3):1605.e1-6. PubMed ID: 25444596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson's disease in a Greek population.
    Karakasis C; Kalinderi K; Katsarou Z; Fidani L; Bostantjopoulou S
    J Clin Neurosci; 2011 Dec; 18(12):1744-5. PubMed ID: 22001244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment.
    Altmann V; Schumacher-Schuh AF; Rieck M; Callegari-Jacques SM; Rieder CR; Hutz MH
    Neurosci Lett; 2016 Feb; 615():88-91. PubMed ID: 26806863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of cortical thinning associated with the BDNF Val66Met polymorphism in Parkinson's disease.
    Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Behav Brain Res; 2019 Oct; 372():112039. PubMed ID: 31202861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
    Ng T; Teo SM; Yeo HL; Shwe M; Gan YX; Cheung YT; Foo KM; Cham MT; Lee JA; Tan YP; Fan G; Yong WS; Preetha M; Loh WJ; Koo SL; Jain A; Lee GE; Wong M; Dent R; Yap YS; Ng R; Khor CC; Ho HK; Chan A
    Neuro Oncol; 2016 Feb; 18(2):244-51. PubMed ID: 26289590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF Val66Met polymorphism is associated with Stage III-IV endometriosis and poor in vitro fertilization outcome.
    Zhang QY; Guan Q; Wang Y; Feng X; Sun W; Kong FY; Wen J; Cui W; Yu Y; Chen ZY
    Hum Reprod; 2012 Jun; 27(6):1668-75. PubMed ID: 22447624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene×gene×gender interaction of BDNF and COMT genotypes associated with panic disorder.
    Konishi Y; Tanii H; Otowa T; Sasaki T; Tochigi M; Umekage T; Motomura E; Shiroyama T; Kaiya H; Okazaki Y; Okada M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():119-25. PubMed ID: 24508446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cognitive function, serum BDNF levels and BDNF gene Val66Met polymorphism in amnestic mild cognitive impairment].
    Yu H; Zhang ZJ; Shi YM; Bai F; Qian Y; Yuan YG; Deng LL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):321-5. PubMed ID: 18460776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of BDNF Val66Met Gene Polymorphism on Serum BDNF and Cognitive Function in Methamphetamine-Dependent Patients and Normal Controls: A Case-Control Study.
    Su H; Tao J; Zhang J; Xie Y; Wang Y; Zhang Y; Han B; Lu Y; Sun H; Wei Y; Zou S; Wu W; Zhang J; Xu K; Zhang X; He J
    J Clin Psychopharmacol; 2015 Oct; 35(5):517-24. PubMed ID: 26280836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship between the rs6265 polymorphism of the BDNF gene and the level of serum neurotrophic factor in patients with Parkinson's disease].
    Nikitina MA; Bragina EY; Nazarenko MS; Levchuk LA; Ivanova SA; Boiko AS; Gomboeva DE; Koroleva ES; Alifirova VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(1):114-120. PubMed ID: 38261293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of common functional MMP12 gene polymorphisms on PD in a Polish population.
    Białecka M; Kurzawski M; Vlaykova T; Tacheva T; Dziedziejko V; Pierzchlińska A; Droździk M
    Neurol Neurochir Pol; 2017; 51(5):347-353. PubMed ID: 28655442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common polymorphism in the brain-derived neurotrophic factor gene in patients with adult-onset primary focal and segmental dystonia.
    Svetel MV; Djuric G; Novakovic I; Dobricic V; Stefanova E; Kresojevic N; Tomic A; Jankovic M; Petrovic I; Pekmezovic T; Kostic VS
    Acta Neurol Belg; 2013 Sep; 113(3):243-5. PubMed ID: 23381842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson's disease: a meta-analysis.
    Wang Q; Liu J; Guo Y; Dong G; Zou W; Chen Z
    Braz J Med Biol Res; 2019; 52(8):e8443. PubMed ID: 31365694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.